Aim: To investigate the relationship between epicardial adipose tissue (EAT) volume and coronary plaque composition. Methods: EAT volume (measured using coronary computed tomography angiography) and coronary plaque characteristics were assessed on a per-segment basis (modified 15-segment American College of Cardiology/American Heart Association classification) in patients with severe coronary artery stenosis. Coronary plaques were classified into four types: 1, calcified plaques; 2, mixed plaques (calcification dominant); 3, mixed plaques (non-calcification dominant); and 4, noncalcified plaques. The gold standard for luminal stenosis was conventional coronary angiography. Results: In 365 patients (mean age 58.7 AE 8.0 years), EAT volume was 169.85 AE 29.94 ml. There were no significant between-group differences in patient characteristics. Statistically significant differences in EAT volume between non-calcified and calcified plaque groups were observed. EAT volume showed a positive correlation with total cholesterol and low-density-lipoprotein cholesterol, and a very weak correlation with age, triglyceride, body mass index and highdensity-lipoprotein cholesterol.
Introduction
Epicardial adipose tissue (EAT) is an unusual visceral adipose tissue that is functionally and anatomically related to the myocardium and coronary arteries. 1 Several studies [1] [2] [3] [4] [5] have shown that EAT plays a significant role in the development of atherosclerosis and is also an independent predictor for coronary artery disease (CAD) under pathological circumstances, through vasocrine or paracrine secretion of inflammatory markers.
Epicardial adipose tissue can easily be detected and measured noninvasively using various medical imaging techniques. Epicardial fat thickness was first visualized and measured in patients with atherosclerosis using echocardiography, which provided a simple, readily available and reproducible assessment. 6 Overall visual imaging of EAT is difficult to acquire using this technique, and although cardiac magnetic resonance imaging provides an accurate measurement, it is more expensive. Due to its high spatial and temporal resolution, computed tomography (CT) is the most widely used imaging technique to measure EAT volume. [7] [8] [9] Advances in coronary CT angiography have enabled identification and characterization of atherosclerotic plaque components, detection of coronary artery stenosis and quantification of EAT volume within the same examination. As shown by several studies, EAT volume measured using CT is an independent marker for the presence and severity of CAD progression, including the degree of stenosis, coronary artery calcium burden and vascular remodeling. [9] [10] [11] Plaque composition has been revealed to vary with the severity of CAD, in that the composition and morphology of plaques and EAT volume appear to change simultaneously with the continuous progression of CAD. 12 Further investigations are required to assess the association between EAT volume and coronary plaque subtypes/ degree of vascular stenosis. Thus, the present study investigated the relationship between EAT volume and coronary plaque components in patients with significant coronary artery stenosis, as defined by CT angiography and conventional coronary angiography.
Patients and methods

Study cohort
Patients with suspected significant coronary artery stenosis (!50%) who received both coronary CT angiography and conventional coronary angiography at the Department of Radiology, The Fourth Affiliated Hospital, Harbin Medical University, Harbin, China, between September 2011 and March 2012 were recruited sequentially into the study. Exclusion criteria comprised a history of coronary revascularization (percutaneous coronary intervention or coronary artery bypass grafting), inadequate imaging quality, cardiac arrhythmias (atrial fibrillation or frequent paroxysmal premature beats), or missing information for one or more conventional cardiovascular risk factors. The study was approved by the Ethics Committee of Harbin Medical University and all patients provided written informed consent.
Imaging protocols
Coronary CT angiography was performed with a 320-row detector volume CT scanner (Aquilion ONE TM ; Toshiba Medical Systems, Nasu, Japan), using variable kV and mA settings based on the patient's body mass index (BMI). Tube voltage and current were 120 kV and 450 mA in patients with a high BMI (!23 kg/m 2 ) and 100 kV and 350 mA in patients with a low BMI (<23 kg/m 2 ). Scanning parameters were as follows: slice thickness, 0.5 mm; field of view, 16 cm; temporal resolution, 175 ms; and scanning time, 1.2-1.6 s. A prospective electrocardiogram (ECG)-gated contrast enhanced acquisition was performed following administration of a 55-80 ml bolus (based on patient's BMI) of non-ionic iodinated contrast agent (Ultravist Õ [iopromide, 370 mg I/ml] Bayer Healthcare Pharmaceuticals, Warrendale, PA, USA) into the antecubital vein using a dual-head power injector (Stellant CT Injector System SCT 18 A, Medrad, Indianola, MS, USA; speed, 5.5 ml/s). A trigger delay of 8-10 s and bolus tracking of contrast material were used. Scanning was started when the contrast bolus arrived in the ascending aorta (>100 Hounsfield units [HU]). Conventional CT angiography volume data were sent to a dedicated workstation (Vitrea Õ fX version 2.1, Vital Images, Plymouth, MN, USA). Measurement of EAT volume, and analysis of the degree of stenosis and plaque composition, were performed for each patient using a cardiac fat and vessel analysis software system (Cardiac: Arteries CT, Toshiba Medical Systems, Nasu, Japan; Figures 1 and 2). Within 1 week of coronary CT angiography, all patients underwent conventional coronary angiography through femoral catheterization using the Seldinger technique (a medical procedure to obtain safe access to blood vessels) with a biplane digital subtraction angiography (DSA) unit (Allura Xper FD20, Philips Healthcare, Best, the Netherlands). Different body position views were obtained as the gold standard for measuring coronary artery stenosis. The effective radiation dose of prospective ECG-gated coronary CT angiography ranged from 1 to 4 mSv.
Assessment of risk factors
Detailed clinical information was obtained for all patients. Hypertension was defined as systolic blood pressure (BP) !140 mmHg and diastolic BP !90 mmHg, or current use of anti-hypertensive medications. Dyslipidaemia was defined as low-density-lipoprotein cholesterol level !3.36 mmol/l on direct measurement, total cholesterol level !5.17 mmol/l, triglyceride level !3 mmol/l and high-density-lipoprotein cholesterol level 1.2 mmol/l, or current use of lipidlowering drugs. Blood glucose disorders were defined as a glycosylated haemoglobin level !6.5% 13 or current use of hypoglycaemic agents. Patients who had smoked regularly during the previous 2 years were defined as current smokers. Details of family history of CAD and diabetes mellitus were obtained by self-reporting. These data, and BMI and waist circumference, were extracted from each patient's notes by D.W.
Classification of coronary plaques
Coronary arteries were classified according to the American College of Cardiology/ American Heart Association modified 15-segment-based classification system. 14 The following definitions were used: singlevessel disease, only one section of the coronary artery or its branch with !50% stenosis; multi-vessel disease, more than one epicardial vessel with !50% stenosis, or left main coronary artery stenosis !50%. Atherosclerotic plaques were divided into two types: 10 calcified plaque, hyperdense lesions composed exclusively of material with a CT density >the contrast-enhanced lumen; or non-calcified plaque, hypodense lesion !1 mm 2 , located within the vessel wall and clearly distinguishable from the contrast-enhanced lumen and surrounding pericardial tissue. Based on the predominant plaque component, patients were grouped according to coronary plaque classification as follows: 15 type 1, calcified; type 2, mixed (calcified >non-calcified component); type 3, mixed (non-calcified >calcified component); and type 4, non-calcified plaque. In multi-vessel disease, plaques were classified according to the major pattern of the plaques. All coronary segments were evaluated by one experienced independent observer (K.W.).
Measurement of EAT volume
Epicardial adipose tissue was defined as the adipose tissue between the pericardium and the epicardial surface of the myocardium, having a density range between À150 and À30 HU. EAT volume was calculated in ml and quantified from the atrial appendage to the cardiac apex using 1 cm-thick spacing between each image, as reported previously. 8 Adipose tissue was automatically recognized and marked in blue by the software (Vitrea Õ fX version 2.1). EAT volume was obtained by hand-sketching the horizontal, sagittal and coronal volume images ( Figure 3 ).
Statistical analyses
Normally distributed parameters are presented as mean AE SD, and categorical variables are presented as absolute values and percentages. Differences between categorical variables were analyzed using 2 -test. Univariate analysis of variance (ANOVA) was first used to compare normally distributed variables (such as EAT volume) between the four coronary plaque groups. To account for multi-factor interactions, multivariate ANOVA was performed followed by post hoc determination of significance using Fisher's least significant difference test. The relationship between EAT volume and risk factors for CAD was assessed using Pearson's correlation coefficient test in patients with severe coronary stenosis grouped into different plaque subtypes. A P value < 0.05 was considered statistically significant. Statistical analyses were performed using SPSS Õ software package, version 15.0 (SPSS Inc., Chicago, IL, USA) for Windows Õ .
Results
Out of 516 consecutive patients with significant coronary artery stenosis (!50%) who had received coronary CT angiography and conventional coronary angiography, 151 were excluded due to a history of coronary revascularization (n ¼ 68), inadequate imaging quality (n ¼ 17), cardiac arrhythmias (n ¼ 39) or missing information for one or more conventional cardiovascular risk factors (n ¼ 27). Thus, 365 patients (235 male and 130 female; age range 35-79 years) were finally included in the analysis (Table 1 ).
Conventional angiography showed that 50.7% (185/365) of patients with significant coronary artery stenosis had multi-vessel disease. Hypertension was observed in 51.2% (187/365) of patients and dyslipidaemia was observed in 66.5% (243/365) of patients (Table 1 ). There were no statistically significant differences in the quantity of vessel lesions, incidence of diabetes mellitus, family history of CAD, age, sex and incidence of smoking between the different coronary plaque types (multivariateadjusted analyses).
A statistically significant differences in EAT volume was observed between the coronary plaque types (F ¼ 14.991, P < 0.001, ANOVA). EAT volume in patients assigned to the type 1 group was significantly lower than for the type 2 (P ¼ 0.010), type 3 (P ¼ 0.002) and type 4 (P < 0.001) groups, assessed using the least significant difference method. There were no significant difference in EAT volume between the coronary plaque type 2 and type 3 groups. EAT volume in the type 4 group was significantly higher than in the type 2 (P < 0.001) and type 3 (P < 0.001) groups (Figure 4) . Epicardial adipose tissue volume showed a very weak positive correlation with age (r ¼ 0.104, P ¼ 0.048), a weak but statistically significant positive correlation with total cholesterol (r ¼ 0.316, P < 0.001) and low-density-lipoprotein cholesterol (r ¼ 0.313, P < 0.001), and a very weak positive correlation with triglyceride (r ¼ 0.120, P ¼ 0.021) and BMI (r ¼ 0.104, P ¼ 0.046). A weak negative correlation was observed between EAT volume and highdensity-lipoprotein cholesterol (r ¼À0.305, P < 0.001). No significant correlation was observed between EAT volume and waist circumference.
Discussion
The present study assessed major cardiovascular risk factors, coronary plaque characteristics and EAT volume in patients with severe coronary artery stenosis, and demonstrated that EAT volume was significantly different between plaque subtypes. EAT volume in the type 1 group was significantly lower than type 2 (P ¼ 0.010), type 3 (P ¼ 0.002), and type 4 (P < 0.001) groups. There was no statistically significant differences in EAT volume between the type 2 and type 3 groups. EAT volume in the type 4 group were significantly higher than the type 2 (P < 0.001) and type 3 (P < 0.001) groups (univariate analysis of variance). The central black horizontal lines for each coronary plaque type represents the mean value; the extremities of the box represent the 25th and 75th percentiles; the error bars represent maximum and minimum values.
EAT volume was shown to correlate with age and indexes of lipid metabolism, suggesting that it might be an independent risk factor for coronary heart disease. 11 Volume CT has the advantage of high spatial and temporal resolution and wide detector coverage, allowing high quality imaging of the coronary arteries for performing accurate measurements of EAT volume within a single heart beat using a small amount of contrast agent. In addition, prospective ECG-gating, as employed in the present study, has been shown to significantly reduce the radiation dose compared with conventional retrospective acquisition techniques. 16, 17 The most recent cardiac fat analysis software (Cardiac: Arteries CT; Vitrea Õ fX version 2.1 workstation) enables precise automatic three-dimensional imaging of EAT. Furthermore, additional information for coronary artery assessment relating to the composition of each obviously obstructive plaque could be obtained using axial slices.
In the present study of patients with severe coronary artery stenosis, the majority were found in the type 2 group (mixed plaques, calcified > non-calcified component), contrasting with a previous study in which most plaques were calcified in patients with mild or severe stenosis. 12 Patients in the present study were divided into four coronary plaque categories according to the classification of plaques reported by Feuchtner et al., 15 and data relating to single-and multi-vessel disease were also separated. The difference in plaque types between the present study and those previosuly reported 12 may be due to endemic and ethnic differences. Most calcified plaques are chronic, stable and non-vulnerable, whereas noncalcified and mixed-density plaques are regarded as vulnerable plaques due to a thinner cap with larger lipid core. 18, 19 In the process of atherosclerosis, the emergence of a low-density plaque indicates the formation of an unstable plaque. 20 The presence of mixed-density plaques in most patients in the present study indicates a need for further investigation into the epidemiological characteristics of Asian populations with severe coronary artery disease. With the exception of EAT volume, there were no statistically significant differences between the coronary plaque subtypes in relation to risk factors or numbers of leisions in patients with severe coronary stenosis, indicating that EAT volume was closely related to plaque composition. In the present study, the noncalcified plaque group had a relatively higher burden of EAT volume (187.61 AE 32.37 ml) compared with the calcified plaque group (169.85 AE 29.94 ml), and EAT volume appeared to vary according to the dynamic formation process of atherosclerotic plaques, consistent with previous studies. 2, 11, 21 Epicardial adipose tissue might contribute to atherosclerosis through the secretion of several harmful adipocytokines and inflammatory cytokines that are involved in the initiation of vascular inflammatory responses. 1 Toll-like receptors have been implicated as initiators of a series of events, leading to translocation of nuclear factor-kB into the nucleus to initiate the transcription of interleukin (IL)-6, IL-1, IL-8, IL-10 and tumour necrosis factor (TNF)-a, followed by the release of IL-6, IL-8, IL-10, TNF-a and resistin. 22 Under physiological conditions, EAT is thought to attenuate coronary artery torsion by specific mechanical effects. 22 Vascular lesions that are surrounded by EAT have been hypothesized to resist expansion more easily than those surrounded by the myocardium, due to its extravascular resistance effect. 23 All of these factors might contribute to the progression of vascular atherosclerosis, and a higher volume of EAT may be a predictor of vulnerable plaque components. [24] [25] [26] The mean EAT volume of 169.85 AE 29.94 ml in the present study was higher than reported in previous studies. 9, 21 One study reported EAT volumes that were statistically significantly different between mild, moderate and severe stenosis coronary groups, with EAT volume of 154.58 AE 58.91 ml in the severe stenosis group. 21 The main reason for the higher EAT volume in the present study might be the inclusion of more overweight subjects, as BMI and waist circumference (25.33 AE 1.98 kg/m 2 and 89.32 AE 11.52 cm, respectively) were higher than those in the normal group of the previous study. 21 EAT volume was shown to have a very weak positive correlation with BMI (r ¼ 0.104, P ¼ 0.0486) in the present study. In addition, the patient cohort in the present study comprised a high proportion of male (64.38%), critical hypertensive (51.2%) and dyslipidemic (66.5%) patients. More than half of patients were smokers, had diabetes, and had a family history of CAD, similar to the features of patients with severe CAD described in previous studies. 12, 24, 27 The present study has several limitations. First, the gold standard for evaluating plaque components, intravascular ultrasound, was not acceptable to the patients due to high cost and invasiveness, thus it was not applied in the present research. Secondly, serum inflammatory marker levels were not obtained in the present study, although they are known to be markers of accelerated atherosclerosis. [28] [29] [30] Further studies are required, therefore, to confirm the correlation between serological inflammatory cytokine levels and EAT volume. Thirdly, since all of the patients in the present study were predominantly of Asian origin with severe CAD, the findings may not be generalized to other populations. Fourthly, the classification standard in multi-vessel disease remains subjective. Thus, the relationship between plaque distributions and EAT volume requires further study. Finally, the pericardial and subcutaneous adipose tissues, which are independent risk factors associated with the severity of CAD and accelerated progression of coronary atherosclerosis, 9, 11 were not measured by CT. Further experiments are required, therefore, to confirm the physiological and pathophysiological differences between subcutaneous and visceral adipose tissue.
In conclusion, the present study showed that EAT volume was associated with plaque characteristics, as detected by coronary CT angiography. In seriously obstructive CAD, most plaques had a mixed composition. EAT volume was higher in patients with non-calcified and mixed plaques. Further investigations regarding the interaction between EAT, bioactive molecules and the development of atherosclerotic plaques are required.
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